... the way for a more contemporary and effective therapies to be developed. There are now 6 FDA-approved therapies that increase overall survival. These include the immunotherapy sipuleucel-T; the 2 androgen pathway inhibitors: abiraterone acetate and enzalutamide; 2 chemotherapy drugs: docetaxel...

... nonseminomatous testicular germ cell tumor, who subsequently developed large volume oligometastases to the retroperitoneum, thorax, and thigh. Despite two regimens of chemotherapy, his disease progressed. Complete surgical extirpation of all gross tumors confirmed mature teratoma. An aggressive surgical approach...

... experienced a disease free condition after chemotherapy and no further progression was found. This could implicate the critical role of early diagnosis in the treatment of SCPCa despite its aggressive nature. © 2012 S. Karger AG, Basel 2012 Copyright / Drug Dosage / Disclaimer Copyright: All rights...

... underwent post chemotherapy RPLND between 1984 and 2007. According to the histology of the RPLND specimen, patients were assigned to the “necrosis-only” group or the “residual tumor” group. Associations between clinical and radiological parameters and histology of RPLND were analyzed. Results: Histology...

... involvement, then little curative benefit may be obtained from surgery. We report urethral recurrence treated via radiation and chemotherapy yielding rapid regression of the tumor and significant palliation. 27 08 2009 10 11 2009 28 1 2010 © 2010 S. Karger AG, Basel 2010 Copyright...

... presented some symptoms suggesting the presence of intracranial disease, and had bulky thoracic disease. After detecting brain metastases, 2 patients had only radiotherapy, 1 patient had chemotherapy plus radiotherapy, 1 patient received chemotherapy, radiotherapy, plus surgery; however, the remaining...